Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.

MLA

Kaltwasser, J.Peter, et al. “Efficacy and Safety of Leflunomide in the Treatment of Psoriatic Arthritis and Psoriasis: A Multinational, Double-Blind, Randomized, Placebo-Controlled Clinical Trial.” Arthritis and Rheumatism, vol. 50, no. 6, June 2004, pp. 1939–50. EBSCOhost, https://doi.org/10.1002/art.20253.

APA

Kaltwasser, J. P., Nash, P., Gladman, D., Rosen, C. F., Behrens, F., Jones, P., Wollenhaupt, J., Falk, F. G., & Mease, P. (2004). Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis and Rheumatism, 50(6), 1939–1950. https://doi.org/10.1002/art.20253

Chicago

Kaltwasser, J Peter, Peter Nash, Dafna Gladman, Cheryl F Rosen, Frank Behrens, Peter Jones, Jürgen Wollenhaupt, Franziska G Falk, and Philip Mease. 2004. “Efficacy and Safety of Leflunomide in the Treatment of Psoriatic Arthritis and Psoriasis: A Multinational, Double-Blind, Randomized, Placebo-Controlled Clinical Trial.” Arthritis and Rheumatism 50 (6): 1939–50. doi:10.1002/art.20253.